Overview of the virtual 2020 FDA's circulatory system devices advisory panel on Neovasc reducer system. (Record no. 10821)

MARC details
000 -LEADER
fixed length control field 02868nam a22004817a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 210607s20212021 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1522-1946
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/ccd.29730 [doi]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 33893757
245 ## - TITLE STATEMENT
Title Overview of the virtual 2020 FDA's circulatory system devices advisory panel on Neovasc reducer system.
251 ## - Source
Source Catheterization & Cardiovascular Interventions. 98(6):1152-1158, 2021 11 15.
252 ## - Abbreviated Source
Abbreviated source Catheter Cardiovasc Interv. 98(6):1152-1158, 2021 11 15.
252 ## - Abbreviated Source
Former abbreviated source Catheter Cardiovasc Interv. 2021 Apr 24
253 ## - Journal Name
Journal name Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2021
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2022
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status aheadofprint
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status ppublish
266 ## - Date added to catalog
Date added to catalog 2021-06-07
268 ## - Previous citation
-- Catheterization & Cardiovascular Interventions. 2021 Apr 24
269 ## - Original dates
Original fiscal year FY2021
520 ## - SUMMARY, ETC.
Abstract Refractory angina is considered a devastating condition with limited medical and therapeutic options. The Neovasc Reducer device, when implanted in the coronary sinus, is designed to alleviate anginal symptoms. However, the available clinical data are sparse. The US Food and Drug Administration (FDA) assembled the Circulatory Systems Devices Panel to discuss the Reducer's safety and effectiveness. Because of the coronavirus disease 2019 pandemic, this meeting was held virtually. In this manuscript, we detail the deliberation and discussion among the circulatory panel members, including their final vote. Copyright (c) 2021 Wiley Periodicals LLC.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *Coronary Sinus
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element *COVID-19
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element SARS-CoV-2
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element United States
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element United States Food and Drug Administration
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Heart & Vascular Institute
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Washington Hospital Center
656 ## - INDEX TERM--OCCUPATION
Department Advanced Cardiac Catheterization Research Fellowship
657 ## - INDEX TERM--FUNCTION
Medline publication type Journal Article
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Medranda, Giorgio
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Waksman, Ron
790 ## - Authors
All authors Medranda GA, Torguson R, Waksman R
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.1002/ccd.29730">https://dx.doi.org/10.1002/ccd.29730</a>
Public note https://dx.doi.org/10.1002/ccd.29730
858 ## - ORCID
ORCID text Medranda, Giorgio A
-- Waksman, Ron
Orcid <a href="https://orcid.org/0000-0001-9804-3786">https://orcid.org/0000-0001-9804-3786</a>
-- <a href="https://orcid.org/0000-0002-4063-9226">https://orcid.org/0000-0002-4063-9226</a>
Name https://orcid.org/0000-0001-9804-3786
-- https://orcid.org/0000-0002-4063-9226
-- https://orcid.org/0000-0001-9804-3786
-- https://orcid.org/0000-0002-4063-9226
858 ## - ORCID
ORCID text Medranda, Giorgio A
-- Waksman, Ron
Orcid <a href="https://orcid.org/0000-0001-9804-3786">https://orcid.org/0000-0001-9804-3786</a>
-- <a href="https://orcid.org/0000-0002-4063-9226">https://orcid.org/0000-0002-4063-9226</a>
Name https://orcid.org/0000-0001-9804-3786
-- https://orcid.org/0000-0002-4063-9226
-- https://orcid.org/0000-0001-9804-3786
-- https://orcid.org/0000-0002-4063-9226
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 06/07/2021   33893757 33893757 06/07/2021 06/07/2021 Journal Article

Powered by Koha